We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 120

Jury to decide whether Novartis caused patient’s ONJ by failing to warn physician

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 28 2014

In a Tennessee case formerly part of multidistrict litigation targeting Novartis for failing to warn physicians that its Aredia and Zometa

Seventh Circuit establishes CAFA jurisdiction guidepost

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 28 2014

In the context of a dispute over health insurance offered to Illinois residents, the Seventh Circuit Court of Appeals has indicated how plaintiffs

Federal court dismisses strict liability claims against drug maker

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 14 2014

Citing a recent Pennsylvania Supreme Court decision reaffirming a long-standing bar on strict liability claims for prescription drugs under the

Eleventh Circuit rules exclusion of expert testimony on basis of industry standards was abuse of discretion

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 14 2014

The Eleventh Circuit Court of Appeals has revived negligence claims filed against Laboratory Corp. of America for allegedly failing to identify

FDA plans to finalize generic drug labeling rule by December 2014

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 19 2014

According to the Department of Health and Human Services' semiannual agenda, the U.S. Food and Drug Administration (FDA) plans to issue a final rule

Vermont Governor signs bill regulating chemicals in children’s products

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 19 2014

Gov. Peter Shumlin (D-Montpelier) has signed into law a bill (S. 239) to regulate the use of toxic chemicals in children's products. Called the

Off-label suture suit against Anulex dismissed as preempted under FDCA

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 19 2014

A North Carolina federal court has dismissed an unfair and deceptive trade practices lawsuit against medical device maker Anulex Technologies, Inc

U.S. Supreme Court denies review in fen-phen fund looting case

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 5 2014

In an order made without comment, the U.S. Supreme Court has declined to examine the decision of the Kentucky Supreme Court that restored a

Sweden to sue EU for delay in endocrine disruptor regulation

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • June 5 2014

Sweden's Environment Ministry has issued a statement indicating that it intends to bring legal action against the European Commission for delays in

Pa. Supreme Court equally divided on protection for attorney-expert communications

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 8 2014

An equally divided Pennsylvania Supreme Court has affirmed a superior court decision adopting the bright-line exclusion from discovery of all